Results 51 to 60 of about 366,746 (310)

TT virus infections among blood donors in Iceland: prevalence, genotypes, and lack of relationship to serum ALT levels. [PDF]

open access: yes, 2009
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldBACKGROUND: The TT virus (TTV) is a newly identified blood-borne virus.
Stanzeit, B   +6 more
core   +1 more source

Frequency and distribution of ABO and Rh blood group systems among blood donors at the Northern Zone Blood Transfusion Center in Kilimanjaro, Tanzania: a retrospective cross-sectional study

open access: yesBMJ Open, 2023
Objectives ABO and Rh blood group systems are the major factors affecting the blood transfusion safety. The frequency and distribution of these blood group systems vary worldwide.
James Yahaya   +5 more
doaj   +1 more source

Blood donors

open access: yesInternational journal of health sciences, 2022
Evaluation of TTI (transfusion transmitted infections) are essential for assessing the safety of blood supply and monitoring the efficacy of currently employed screening procedures. Objective: To assess the prevalence of HBV, HCV and HIV among replacement donors and voluntary donor in association with the Kuppuswamy’s socioeconomic status. Material and
Jyotsana Khattri   +3 more
openaire   +1 more source

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla   +6 more
wiley   +1 more source

Rhesus blood group haplotype frequencies among blood donors in southwestern Uganda [PDF]

open access: yes, 2018
Yona Mbalibulha,1 Enoch Muwanguzi,1 Godfrey Mugyenyi2 1Department of Medical Laboratory Sciences, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; 2Department of Obstetrics and Gynecology, Faculty of Medicine, Mbarara ...
Mugyenyi G, Mbalibulha Y, Muwanguzi E
core  

Optimization of blood testing strategies for voluntary blood donors in military blood centers [PDF]

open access: yes, 2022
Objective To explore the optimization of blood testing strategies for voluntary blood donors in military blood centers. Methods From January 2017 to December 2020, the testing results of five serological indicators of voluntary blood donors from our ...
Ting ZHANG, Limei FEGN
core   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol   +6 more
wiley   +1 more source

Iron stores in regular blood donors in Lagos, Nigeria [PDF]

open access: yes, 2013
Adewumi Adediran,1 Ebele I Uche,2 Titilope A Adeyemo,1 Dapus O Damulak,3 Akinsegun A Akinbami,4 Alani S Akanmu1 1Department of Hematology and Blood Transfusion, University of Lagos, Lagos, Nigeria; 2Department of Hematology and Blood Transfusion, Lagos ...
Uche EI   +5 more
core  

BMT4me En Español: Multisite Feasibility and Usability Testing of a Spanish‐Language mHealth Adherence Support App for Spanish‐Speaking Caregivers of Children After Hematopoietic Stem Cell Transplantation and Cancer Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens   +4 more
wiley   +1 more source

Thalassaemia screening among healthy blood donors in Hospital Tengku Ampuan Rahimah, Klang [PDF]

open access: yes, 2014
Thalassaemia screening programme has been conducted in Malaysia since 2004. The aim of the programme was to reduce the burden of the disease by identifying thalassaemia carriers.
Asidin, Norhanim   +11 more
core  

Home - About - Disclaimer - Privacy